News & Analysis as of

Technology Patents Doctrine of Equivalents

McDermott Will & Emery

The Devil Is in the Details: Bioequivalence, In Vitro Testing Not Enough to Establish Infringement

McDermott Will & Emery on

Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed release portions infringed on a...more

Schwabe, Williamson & Wyatt PC

Latest Federal Court Cases - December 2024

Mirror Worlds Technologies, LLC v. Meta Platforms, Inc., Appeal Nos. 2022-1600, -1709 (Fed. Cir. Dec. 4, 2024) In this appeal from the United States District Court for the Southern District of New York, the Federal...more

Bradley Arant Boult Cummings LLP

Federal Circuit Breathes Life Back into Clean Coal Technology Suit

After a series of “Dead on Arrivals” from the Northern District of Illinois, the Federal Circuit on Tuesday resuscitated a patent infringement suit filed by Nalco Company against Chem-Mod, LLC, and others in the Northern...more

Knobbe Martens

Federal Circuit Review - Volume 2 | Issue 11 November 2012

Knobbe Martens on

In This Issue: • Doctrine of Equivalents: What Constitutes a Disclosed but not Claimed Equivalent? • When “Each” Means “Every”: Apple Loses a Round in Its Ongoing Battle with Samsung • Capturing Advances in...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide